Table 1.
Patient inclusion demographics
| Control group n (%) | Voice rehabilitation n (%) | Difference p value | |
|---|---|---|---|
| Patients | 32 | 31 | |
| Gender | 0.96 | ||
| Male | 28 (87) | 27 (87) | |
| Female | 4 (13) | 4 (13) | |
| Mean age (years) | 62.1 | 65.8 | 0.19 |
| Range | 41–82 | 41–86 | |
| Tumour location | 0.59 | ||
| Glottic (78%) | 24 (75) | 25 (81) | |
| Tis | 1 | 0 | |
| T1 | 15 | 19 | |
| T2 | 7 | 6 | |
| T3 | 1 | 0 | |
| Supraglottic (22%) | 8 (25) | 6 (19) | |
| T1 | 1 | 2 | |
| T2 | 3 | 2 | |
| T3 | 4 | 1 | |
| T4 | 0 | 1 | |
| Radiotherapy | 0.46 | ||
| Conventional | 23 (72) | 19 (61) | |
| Hyperfractionated | 9 (28) | 12 (39) | |
| Comorbidity (ACE-27)a | (n = 31)b | 0.22 | |
| None | 13 = (42) | 13 = (42) | |
| Mild | 14 = (45) | 9 = (29) | |
| Moderate | 4 = (13) | 9 = (29) | |
| Severe | 0 | 0 | |
| Working status—employed | 14 (44) | 12 (39) | 0.69 |
| Vocally demanding workc | 7/14 (50) | 7/12 (58) | 0.95 |
aAdult Comorbidity Evaluation (ACE-27) [35]
bOne patient with missing data
cAs determined by patient report